136 results
-
HISO 10072.2:2019 Bowel Screening Histology Data Standard – Draft for public comment
You are invited to review and provide comment on the draft Bowel Screening Histology Data Standard. The National Bowel Screening Programme is a free programme for men and women aged 60–74 years eligible for publically funded health care. The primary objective of bowel screening is to reduce the mortality rate by diagnosing and treating bowel cancer at an earlier more treatable stage. A new system, called the National Screening Solution, is currently in development and will receive... MoreClosed 29 March 2019 -
Code of Practice for Industrial Radiography: Draft for consultation
The Radiation Safety Act 2016 came fully into force on 7 March 2017. The Act is administered by the Ministry of Health’s Office of Radiation Safety. The Act sets out high-level safety and security obligations in sections 9–12. There are many different types of radiation use and the requirements are often very technical. The Act therefore authorises the issuing of codes of practice to set out more detailed requirements relating to individual areas of practice. This code relates to... MoreClosed 29 March 2019 -
Second round of consultation on the proposed donation and surrogacy guidelines
This is a second round of consultation, following our consultation in 2017, on ACART’s proposed changes to the guidelines for family gamete donation, embryo donation, the use of donated eggs with donated sperm (donated eggs/donated sperm) and clinic-assisted surrogacy (collectively, the Donation Guidelines review). ACART is inviting submissions on three matters it has reconsidered since the first round of consultation. Although ACART has confirmed its intention to rescind the mandatory... MoreClosed 25 March 2019 -
Therapeutic Products Christchurch Forum Registration
Consultation on an exposure draft of the Therapeutic Products Bill and an associated consultation paper is underway. The Bill is intended to repeal and replace the Medicines Act 1981 and establish a new regulatory scheme for therapeutic products. MoreClosed 14 March 2019 -
Code of Practice for the Safe Transport of Radioactive Material
This document sets out possible wording for a new code of practice to be issued under the Radiation Safety Act 2016 for the safe transport of radioactive material by road, rail, sea and air. The Act sets out high-level safety and security obligations in sections 9–12. There are many different types of radiation use and the requirements are often very technical. The Act therefore authorises the issuing of codes of practice to set out more detailed requirements relating to individual... MoreClosed 1 March 2019 -
Therapeutic Products - Events Registration of Interest
Consultation on an exposure draft of the Therapeutic Products Bill and an associated consultation paper is underway. The Bill is intended to repeal and replace the Medicines Act 1981 and establish a new regulatory scheme for therapeutic products. MoreClosed 6 February 2019 -
Therapeutic Products Information Forum Registration
Consultation on an exposure draft of the Therapeutic Products Bill and an associated consultation paper is underway. The Bill is intended to repeal and replace the Medicines Act 1981 and establish a new regulatory scheme for therapeutic products. MoreClosed 22 January 2019 -
Hearing the stories of those harmed by surgical mesh
As part of its response to ongoing concerns with the use of surgical mesh, the Ministry of Health is wanting to provide an opportunity for people who have been harmed by surgical mesh and their families/whānau to tell their stories. It is important that any such opportunity is inclusive and supportive of people’s different needs and situations. Therefore, we would like to hear from those who are interested in telling their story, about how they would like to do this. You could be... MoreClosed 18 January 2019 -
Guidance for best practice management - National Bowel Screening Programme
The National Bowel Screening Programme (NBSP) is a significant investment in reducing disease and death from one of New Zealand’s biggest cancer killers. The NBSP is our first screening programme for both men and women and, when fully implemented, is expected to detect 500 to 700 cancers every year, in the early stages. The development of these clinical guidelines aims to embed best practice clinical management across the screening pathway and ensure quality and consistency. MoreClosed 18 January 2019 -
Proposed warning statement regarding a fire hazard on the labels of paraffin-based skin products
Medsafe is seeking comments on a proposed warning statement regarding a fire hazard on the labels of paraffin-based skin products. This risk was identified by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK. The MHRA have received reports in which an individual using one or more paraffin-based skin product has died after their clothes and/or bedding caught fire. The MHRA published a reminder for healthcare professionals in April 2016 . ... MoreClosed 7 December 2018 -
Weight Management Tools
This short survey will help the Ministry of Health to have a better understanding of growth and weight monitoring in New Zealand and how Practice Management Systems could assist health practitioners with this task. MoreClosed 1 October 2018 -
Strategy to Prevent and Minimise Gambling Harm 2019/20 to 2021/22
This document seeks your comment on the proposed future direction and content of the Ministry of Health’s Strategy to Prevent and Minimise Gambling Harm 2019/20 to 2021/22. Your feedback is vital to help us develop the final strategy. Included are draft proposals for: the strategic plan, which sets out the general strategic direction and priorities that provides a framework for the activities described below the proposed funding levels for the Ministry, in... MoreClosed 28 September 2018 -
Consultation on the Draft National Ethics Standards for Health and Disability Research
The National Ethics Advisory Committee (NEAC) is an independent advisor to the Minister of Health. NEAC was established in 2001 by section 16 of the New Zealand Public Health and Disability Act 2000. The National Ethics Advisory Committee’s statutory functions are to: provide advice to the Minister of Health on ethical issues of national significance in respect of any health and disability matters (including research and health services) determine nationally consistent... MoreClosed 28 September 2018 -
Posthumous Reproduction: A review of the current Guidelines for the Storage, Use, and Disposal of Sperm from a Deceased Man to take into account gametes and embryos
Posthumous reproduction involves the use of a person’s sperm or eggs, after their death. In some cases, it also involves the retrieval of these gametes very shortly after death or at a time when death is imminent. While scientific advances have made this form of reproduction possible, there are many complex ethical and legal issues that have not yet been resolved. For example, the existing Guidelines, written in 2000 apply only to the posthumous use of sperm that was retrieved prior to the... MoreClosed 14 September 2018 -
Proposed changes to the National Health Index (NHI) system and HISO 10046, the Consumer Health Identity Standard
The Ministry of Health is considering undertaking a number of changes to the National Health Index (NHI) system. Changes made will be included in the associated Consumer Health Identity Standard . We seek comment to assist in establishing a) if a particular proposal should proceed at a concept level, and b) a relative priority for each proposal. Some changes are essential to maintaining the operating life of the NHI system – for example, the proposed extension to the NHI numbering... MoreClosed 24 August 2018 -
Update to the Guideline on the Regulation of Therapeutic Products – Part 11: Clinical trials
This consultation is aimed at pharmaceutical companies, health care professional organisations, and individuals involved in conducting, or who are subjects of, clinical trials of medicines. Medsafe sought comment on a major revision of the Guideline on the Regulation of Therapeutic Products in New Zealand. Part 11: Clinical trials – regulatory approval and good clinical practice requirements. Part 11 of the regulatory guideline was last reviewed in January 2015. Since then,... MoreClosed 10 August 2018
136 results.
Page 5 of 5